Who are Shade Uvaguard's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Hydroquinone Methyl Ether, Infuvite Adult, Hydroquinone cream, Tri-luma, Ascaricid, Arbutyne.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/avobenzone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Shade Uvaguard — Competitive Intelligence Brief

Shade Uvaguard (AVOBENZONE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: avobenzone. Area: Dermatology.

marketed avobenzone Tyrosinase Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Shade Uvaguard (AVOBENZONE) — Bayer. Shade Uvaguard works by absorbing and scattering UV radiation to prevent skin damage.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Shade Uvaguard TARGET	AVOBENZONE	Bayer	marketed	avobenzone	Tyrosinase	1992-01-01
Hydroquinone Methyl Ether	MEQUINOL		marketed	Skin Lightening Agent	Tyrosinase	1999-01-01
Infuvite Adult	ASCORBIC ACID		marketed	Vitamin C [EPC]	Tyrosinase	1985-01-01
Hydroquinone cream	Hydroquinone cream	National Skin Centre	marketed	Depigmenting agent	Tyrosinase
Tri-luma	Tri-luma	Hexsel Dermatology Clinic	marketed	Topical depigmenting agent combination	Tyrosinase; retinoic acid receptor; glucocorticoid receptor
Ascaricid	hexylresorcinol		marketed	hexylresorcinol	Arachidonate 5-lipoxygenase, Tyrosinase, Polyphenol oxidase 2
Arbutyne	ARBUTIN		marketed	Adenosine Receptor Agonist [EPC]	Tyrosinase, Polyphenol oxidase 2, Tyrosinase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (avobenzone class)

Bayer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Shade Uvaguard — Competitive Intelligence Brief. https://druglandscape.com/ci/avobenzone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab